Resumen de acción CL
Colgate-Palmolive Company, junto con sus filiales, fabrica y vende productos de consumo en Estados Unidos y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Recompensas
Análisis de riesgos
Narratives
BetaNarratives bring a range of perspectives from our community.
Warren
Based on Analyst Price Targets
Price at publication US$87.72
Updated
Competidores de Colgate-Palmolive Company
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$89.29 |
| 52 Week High | US$90.37 |
| 52 Week Low | US$67.62 |
| Beta | 0.41 |
| 1 Month Change | 0.44% |
| 3 Month Change | 7.80% |
| 1 Year Change | 14.58% |
| 3 Year Change | 11.86% |
| 5 Year Change | 24.32% |
| Change since IPO | 9,558.41% |
Noticias y actualizaciones recientes
Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02
Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Recent updates
Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly
Jun 05Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)
May 18Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Feb 23Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)
Feb 05What to expect from Colgate-Palmolive's Q4 2022 Earnings
Jan 26Colgate-Palmolive declares $0.47 dividend
Jan 12Lorrie Norrington named lead independent director of Colgate
Jan 03Colgate-Palmolive (NYSE:CL) Will Be Hoping To Turn Its Returns On Capital Around
Jan 01Colgate-Palmolive: I Like The Toothpaste But Not The Stock
Dec 22Colgate-Palmolive: Good Long-Term Prospects But Fairly Valued
Dec 07Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Nov 16Colgate-Palmolive Q3 2022 Earnings Preview
Oct 27Colgate gains on report activist Third Point takes stake
Oct 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 45% Discount?
Oct 11Colgate-Palmolive: 'Boring' Remains Attractive In The Current Market Environment
Sep 29Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Sep 23Colgate-Palmolive declares $0.47 dividend
Sep 09CP India names Prabha Narasimhan as MD, CEO
Sep 01Colgate-Palmolive: What Recent Results Mean For Long-Term Holders
Aug 25Rentabilidad de los accionistas
| CL | US Household Products | Mercado US | |
|---|---|---|---|
| 7D | 3.0% | 3.7% | 1.0% |
| 1Y | 14.6% | 4.7% | 21.9% |
Rentabilidad vs. Industria: CL superó al sector US Household Products , que obtuvo un rendimiento del 6.4% el año pasado.
Rentabilidad vs. Mercado: CL obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| CL volatility | |
|---|---|
| CL Average Weekly Movement | 1.6% |
| Household Products Industry Average Movement | 2.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: CL no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CL (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1806 | 34,000 | Noel Wallace | www.colgatepalmolive.com |
Colgate-Palmolive Company, junto con sus filiales, fabrica y vende productos de consumo en Estados Unidos y a escala internacional. Opera a través de dos segmentos: Cuidado Oral, Personal y del Hogar; y Nutrición de Mascotas. El segmento de Cuidado Oral, Personal y del Hogar ofrece dentífricos, cepillos de dientes, enjuagues bucales, jabones de manos líquidos y en barra, geles de ducha, champús, acondicionadores, desodorantes y antitranspirantes, productos para la salud de la piel, detergentes lavavajillas, acondicionadores de tejidos, limpiadores domésticos y otros artículos relacionados.
Resumen de fundamentos de Colgate-Palmolive Company
| Estadísticas fundamentales de CL | |
|---|---|
| Capitalización bursátil | US$73.40b |
| Beneficios(TTM) | US$2.30b |
| Ingresos (TTM) | US$19.46b |
31.9x
Ratio precio-beneficio (PE)3.8x
Ratio precio-ventas (PS)¿Está CL sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CL | |
|---|---|
| Ingresos | US$19.46b |
| Coste de los ingresos | US$8.13b |
| Beneficio bruto | US$11.33b |
| Otros gastos | US$9.03b |
| Beneficios | US$2.30b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
Apr 26, 2024
| Beneficios por acción (BPA) | 2.80 |
| Margen bruto | 58.22% |
| Margen de beneficio neto | 11.82% |
| Ratio deuda/patrimonio | 887.8% |
¿Cómo se ha desempeñado CL a largo plazo?
Ver rendimiento histórico y comparativa